GASTROENTERITIS NORWALK VIRUS

This adverse event was reported 19 times

GASTROENTERITIS NORWALK VIRUS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 2 0.0011
1 DICLOFENAC SODIUM AND MISOPROSTOL 1 0.0002
2 ATOVAQUONE 1 0.0001
3 QUININE 1 0.0001
4 ASCORBIC ACID 1 0.0000
5 ATOMOXETINE HYDROCHLORIDE 1 0.0000
6 RABEPRAZOLE SODIUM 1 0.0000
7 VORICONAZOLE 1 0.0000
8 FILGRASTIM 1 0.0000
9 OLANZAPINE PAMOATE 1 0.0000
See all drugs enriched for association with GASTROENTERITIS NORWALK VIRUS

GASTROENTERITIS NORWALK VIRUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Skin Test Antigen [EPC] 2 0.0011
1 Antimalarial [EPC] 1 0.0001
2 Antiprotozoal [EPC] 1 0.0001
3 Prostaglandin E1 Analog [EPC] 1 0.0001
4 Antirheumatic Agent [EPC] 2 0.0000
5 Purine Antimetabolite [EPC] 1 0.0000
6 Fluoroquinolone Antibacterial [EPC] 1 0.0000
7 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
8 Leukocyte Growth Factor [EPC] 1 0.0000
9 Calcium [EPC] 1 0.0000
See all drug classes enriched for association with GASTROENTERITIS NORWALK VIRUS